News

News > Longevity 2020Early access to the treatment of aging: distinguishing rational self-experimentation from arrant foolishness

Early access to the treatment of aging: distinguishing rational self-experimentation from arrant foolishness

Author: Phil Newman | Published on: May 1, 2020 | Last updated: May 10, 2022

Reason

Co-founder and CEO, Repair Biotechnologies & Fight Aging!

Early access to the treatment of aging: distinguishing rational self-experimentation from arrant foolishness

Share this article:

Editor's choice

Empowering cells to boost energy and recovery is a winning move

Study disproves benefits of probiotics for vaginal health

How do Tour De France athletes recover so fast? Performance coach reveals the secret

9 proven ways to beat brain fog and enhance your energy

Longevity investment platform opens-up to international investors

Urolithin A research opens door to osteoarthritis relief

Popular articles

Longevity Biomedical and SPAC Denali to create Nasdaq-listed longevity biopharm company

A decade of research expands the Hallmarks of Aging from nine to twelve

Longevity investment bulletin: Juvena, eGenesis, Springs Rejuvenation and more

Petr Sramek: Now is the right time to invest in longevity

Researchers identify small molecule that restores visual function after optic nerve injury

Hypertension drug rilmenidine can extend lifespan and slow aging

More like this

The youthful side of longevity

Mark Cuban and Peter Diamandis among celebs in biggest longevity film to date: Longevity Hackers

Improving your cardiovascular health to help maintain a healthy lifestyle

Cyclarity’s guardians are leading the battle against atherosclerosis

Longevity medicine education at a grassroots level will effect global change

Healthy Longevity Guide – highlighting the possibilities of longevity to physicians and wellness professionals

Changing healthcare forever and funding the new longevity economy

Spermidine – the supplement making an impact

Constructively disruptive – tackling atherosclerosis through disease reversal

Education is key to healthy longevity at scale

Marc P Bernegger – making longevity tangible for everybody as soon as possible

Tobias Reichmuth – the longevity market starts now

Brian Kennedy – validating aging interventions and why rapamycin is the gold standard

Charles Brenner: longevity is not a simple engineering problem

Aubrey de Grey on longevity at scale

Back to biology – Eric Verdin talks NMN and longevity supplements

Find us here ...

© Copyright 2022 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY

First Longevity Ltd is an appointed representative of Prospect Capital Ltd which is authorised and regulated by the Financial Conduct Authority.
The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding and knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.